Lv2
150 积分 2024-05-19 加入
Using TCR-CAR dual signaling for precise cancer targeting
2个月前
已完结
Donafenib inhibits PARP1 expression and induces DNA damage, in combination with PARP1 inhibitors promotes apoptosis in liver cancer cells
4个月前
已完结
Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells
5个月前
已完结
Pure laparoscopic full-size liver transplantation in adult
6个月前
已完结
Targeting chaperone-mediated autophagy in neurodegenerative diseases: mechanisms and therapeutic potential
7个月前
已完结
Proteomic analysis of gemcitabine-induced drug resistance in pancreatic cancer cells
7个月前
已完结
LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway
8个月前
已完结
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy
1年前
已完结
Recent Progress in Gemcitabine-Loaded Nanoparticles for Pancreatic Cancer Therapy: A Review
1年前
已完结
Targeted Degradation of PD‐L1 and Activation of the STING Pathway by Carbon‐Dot‐Based PROTACs for Cancer Immunotherapy
1年前
已完结
皖公网安备34019202002308
